Clinical Trials Using C3-targeted Complement Inhibitor APL-2
Clinical trials are research studies that involve people. The clinical trials on this list are studying C3-targeted Complement Inhibitor APL-2. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Study to Evaluate the Efficacy and Safety of APL-2 in Patients With PNH
Evaluation of the Efficacy and Safety of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria
Location: See Clinical Trials.gov
Multi-center Extension Study to Evaluate the Long Term Safety and Efficacy of APL-2 in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
This is an Open Label, Non-Randomized, Multi-Center Extension Study for ongoing and planned Phase IB, Phase II, and Phase III studies with APL-2 in subjects with PNH.
Location: Case Comprehensive Cancer Center, Cleveland, Ohio